Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "University of California College of"


4 mentions found


"It was harder than the initial assault," Kostial said of being stalked. The Aetna NDA only silenced her about the terms of her settlement, not the sexual assault. Kostial has discussed her situation with Vincent White, a New York city-based lawyer who specializes in workplace NDAs and advises signatories on the risks associated with breaking them. Kostial is fearful that if they wed, her wife's finances could be affected if either SAP or Aetna pursues her for breaking her NDA. AdvertisementWhenever she's seized by anxiety, Kostial reminds herself of how hard she's fought to move past the sexual assault and why she's coming forward.
Persons: , Ashley Kostial, she'd, She'd, Kostial, abrasions, Aetna, Brad Schleier, Schleier, hadn't, NDAs, Taylor Glascock, Kira, She's, Nina Wasow, Jodi Short, Evan Starr, Morton , Illinois Taylor Glascock, galling, Vincent White, White, Zelda Perkins, Harvey Weinstein's, Julie Macfarlane, she's, Hey Ashley —, he'd Organizations: Service, SAP, Marriott, Business, Ariba, Aetna, Aetna NDA, BI, University of California College of the, San, National Labor Relations Board, University of, Plano Police Department Locations: Plano , Texas, Plano, Phoenix, spokespeople, Aetna, Berkeley , California, California, New York, New, Maryland , New Jersey, New Mexico, But Arizona, San Francisco, NDAs, Morton ,, Oakland, Texas, Arizona, Illinois
And Bristol Myers Squibb is trying protect its blood thinner Eliquis, which brought in $11.8 billion in sales last year, or about 25% of the company's $46 billion total revenue for 2022. Long legal battle aheadMerck, the chamber and Bristol Myers Squibb filed their lawsuits ahead of two key deadlines. Bristol Myers Squibb did not either. If circuit court decisions on the matter contradict one another, the Supreme Court would step in to decide the issue, Bagby said. Bristol Myers Squibb made an identical argument in its complaint.
Persons: Richard A, Gonzalez, Pascal Soriot, Giovanni Caforio, Jennifer Taubert, Johnson, Kenneth C, Frazier, Albert Bourla, Olivier Brandicourt, Win Mcnamee, Drugmaker Merck, Drugmaker, Bristol Myers Squibb, PhRMA, Eli Lilly, Merck, Bristol Myers, Robin Feldman, Nicholas Bagley, Bagley, Gretchen Whitmer, Chris Meekins, Raymond James, Antonin Scalia, Brett Kavanaugh, Neil Gorsuch, Meekins, Long, Xavier Becerra, Randolph Daniel Moss, Barack Obama, Judge Thomas M, Rose, George W, Bush, Kelly Bagby, Bagby, Amgen, Donald Trump, Karine Jean, Pierre, Biden, Jean, we'll, Becerra, Feldman Organizations: Senate, AbbVie Inc, AstraZeneca, Myers Squibb Co, Janssen Pharmaceuticals, Johnson, Merck & Co, Inc, Pfizer, Sanofi, Getty, U.S . Chamber of Commerce, Bristol Myers Squibb, Washington , D.C, Southern, Southern District of, Democratic Party, U.S, Merck, Bristol, Pharmaceutical Research, Manufacturers of America, CNBC, Medicare, University of California College of, Justice Department, Michigan Gov, Bristol Myers, Human Services, Centers, Services, AARP Foundation, HHS, AARP, Specialty Pharmacy, Reuters, Supreme, Appeals, Democratic, U.S . Sixth, Republican, Third, White Locations: America, Washington , DC, Bristol, U.S, Washington ,, Southern District, Southern District of Ohio, New Jersey, Commerce's Dayton , Ohio, San Francisco
Bosses hate work from home because 'home' is for women
  + stars: | 2023-04-17 | by ( Aki Ito | ) www.businessinsider.com   time to read: +10 min
And the old way was clear: The office is for work, and the home is for — well, for whatever unpaid stuff it is that women do while their men are at work. Skeptical that work — real work — could be done at home, bosses quietly penalized the women who opted for flexible schedules by sticking them with boring assignments and denying them promotions. Embracing remote work is a good start, but it comes with risks of its own. Since the pandemic hit, I've heard a few CEOs liken remote work to opening Pandora's box. Women working from home are no longer the aberration — tradition-bound executives are.
A provision in the Inflation Reduction Act that allows Medicare to negotiate prices on the costliest prescription drugs each year will likely save the U.S. billions of dollars — as long as the drug industry doesn't interfere, according to a study published Friday in JAMA Health Forum. They identified 40 drugs that would have been selected by Medicare for drug pricing negotiation under the Inflation Reduction Act's provision. The researchers simulated negotiated prices by using a so-called ceiling price, which is at least 25% off the average price drug manufacturers charge to nongovernment entities, like private health insurance providers. The researchers found that the Medicare drug negotiation provision would have saved the U.S. $26.5 billion, or 5% of all drug spending, during those three years. It plans to release a list of the first 10 drugs it will target for drug pricing negotiation by September.
Total: 4